GELS (Gelteq Limited Ordinary Shares) Stock Analysis - AI Report

Gelteq Limited Ordinary Shares (GELS) is a publicly traded Healthcare sector company. As of May 21, 2026, GELS trades at $0.46 with a market cap of $4.34M and a P/E ratio of 0.00. GELS moved +27.74% today. Year to date, GELS is -43.11%; over the trailing twelve months it is -73.39%. Its 52-week range spans $0.39 to $5.50. Rallies surfaces GELS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on GELS?

Rallies AI research for GELS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

GELS Key Metrics

Key financial metrics for GELS
MetricValue
Price$0.46
Market Cap$4.34M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$5.50
52-Week Low$0.39
Volume1.95K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest GELS News

GELS Analyst Consensus

GELS analyst coverage data. Average price target: $0.00.

Common questions about GELS

What is the AI research view on GELS?
Rallies AI research for GELS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for GELS?
Rallies AI research for GELS combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is GELS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GELS. It does not provide personalized investment advice.
GELS

GELS